Fabienne Iten

1 ta ish

1Institute of Nuclear Medicine,

1. Response to [90Yttrium-DOTA]-TOC Treatment is Associated with Long-term Survival Benefit in Metastasized Medullary Thyroid Cancer: A Phase II Clinical Trial

   Fabienne Iten, Beat P. Müller‐Stich, Christian Schindler +5

   MaqolaThyroid Cancer Diagnosis and TreatmentClinical Cancer Research20070 iqtibos

   ABIABI:AkademIndex/openalex/2007.article.000008